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Calcification is the most important cause of structuraldeterioration of glutaraldehyde-fixed bioprosthetic
valves.1,2 Glutaraldehyde treatment, tissue devitaliza-
tion, and mechanical stress have been postulated to pro-
mote calcification when the bioprostheses are implant-
ed in vivo, either in the orthotopic or subdermal
position.3-8 The extent and progression of calcification
depends also on host factors, such as age, renal func-
tion, pregnancy, and other unknown determinants, but
host-graft interaction is not essential for mineralization
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development. In fact, calcification can be reproduced in
vitro by using pulsatile testing devices with an appro-
priate solution.9,10 The objective of this investigation
was to provide evidence that calcification induced in
vitro is similar to that occurring spontaneously in vivo.
Material and methods
Four porcine frame-mounted bioprostheses (St Jude Medical
Bioimplant; St Jude Medical, Inc, St Paul, Minn) were tested in
vitro with a pulsatile accelerated calcification testing device
(Fig 1). A rapid synthetic calcification fluid was developed by
means of modification of the solution according to the method
of Starcher and Urry.11 In our preliminary studies,9 isolated
leaflets were placed in different solutions without mechanical
stress to find the ideal solution. Eventually, a solution was cho-
sen with a pH of 7.4 and a final product (calcium × phosphate)
of 130 mg/dL2, which is comparable with that of bovine plas-
ma solution (not suitable for prolonged testing because of
infection risk and cost). Calcification was negligible without
mechanical stress. The pulsatile accelerated testing device was
constructed according to the standards published by the US
Food and Drug Administration (FDA).12 Although not FDA
approved, our test device is even more sophisticated with
respect to special requirements for bioprostheses of FDA
guidelines because it allows full opening and closing of the
leaflets. The device is made of 10 separate test chambers con-
taining the valve within the calcification fluid. All test cham-
bers were sterilized with ethylene oxide. Each valve was
mounted within a separate compartment and tested at frequen-
cies of 300 cycles per minute at 37˚C. Preliminary studies
allowed the choice of test frequency, number of cycles, and test
duration.9,10 Test frequency was chosen to meet one demand,
namely, acceleration of testing by preserving full opening and
closing of valve leaflets. The test duration and number of
cycles were established by means of a weekly inspection of
valve calcification through gross and x-ray examination during
the test period. Simultaneous pressure monitoring on both sides
of the bioprostheses was performed to assess occurrence of
valve stenosis and incompetence. Further details are described
in previous articles.9,10 The pressure difference across the
valves was adjusted at 120 mm Hg. The calcification medium
was changed weekly, and depletion of calcium and phosphate
was measured by atomic absorption spectroscopy for each
compartment as indirect evidence of calcium and phosphate
precipitation into the bioprosthetic tissue. At the end of every
test week, the mean of calcium concentration in the test fluid
varied from 1.07 to 2.03 mmol/L, and the phosphate concen-
tration varied from 1.12 to 2.33 mmol/L. Precipitation on the
walls of the chamber was excluded. The test was terminated
after 19 × 106 cycles. Each specimen underwent gross and
mammography x-ray examination, and calcium deposits were
assessed semiquantitatively as follows: score 0, none; score 1,
focal, pinpoint, <1 mm; score 2, focal, >1 mm, or multiple pin-
point; score 3, multiple, large; and score 4, massive.1 For his-
tology, samples from each cusp were formalin fixed and paraf-
fin embedded; 5- to 7-µm thick sections were stained with
hematoxylin and eosin, Weigert-Van Gieson, and Heidenhein
tricrome stains and Von Kossa counterstained with neutral red.
For transmission electron microscopy (TEM), samples were
fixed in Karnovsky solution, postfixed in 1% osmium tetrox-
ide, dehydrated in alcohol, and embedded in epoxy resin.
Semithin sections were stained with 0.1% toluidine blue for
light microscopic examination. Ultrathin sections were stained
with uranyl acetate and lead citrate and examined with a
Hitachi H-7000 microscope (Hitachi, Ltd, Tokyo, Japan). For
scanning electron microscopy, samples of each specimen were
dehydrated through a graded ethanol series and in amyl acetate
and finally dehydrated at the critical point drying with carbon
dioxide. The specimen was then coated with gold-platinum
film and observed with a Philips XL30 TMP electron micro-
scope (Philips Electronics N.V., Eindhoven The Netherlands).
For assessment of calcium content, samples of bioprostheses
were dried to a constant weight in a desiccator oven and incu-
bated with HNO3 (0.75 mol/L) at 68˚C for 15 hours. After cen-
trifugation at 2500g, the fluid removed was diluted, and the
calcium content was determined by means of atomic absorp-
tion spectroscopy. Elemental concentrations were expressed
throughout as milligrams per gram of dry tissue weight.
Fragments of the 4 in vitro tested bioprostheses were submit-
ted to x-ray powder diffraction analysis (XRPD). For the
analysis, we used a Philips PW 3710 diffractometre operating
with Bragg-Brentano geometry. Experimental conditions were
40 kV and 20 mA, with CuKα1,2 radiation; data collections
were carried out by scanning the 2-range from 24˚ to 55˚ and
using the step-by-step method with a step width of 0.02˚ and a
counting time of 2 seconds per step. After XRPD investigation,
a fragment was then embedded in epoxy resin, cut, and pol-
ished. The sample, coated with a 200-Å layer of carbon, was
submitted to a CAMECA-CAMEBAX electron microprobe
(electron microprobe analysis [EMPA]) (CAMECA, Paris,
France) to study the chemical composition of mineralized
areas. Operating conditions of the instrument, equipped with 4
wavelength dispersive spectroscopy x-ray spectrometers, were
15 kV and 15 nA sample current and counting time of 10 sec-
onds at the peak and 10 seconds at the background. Analyses
were performed against synthetic end-member mineral stan-
dards. X-ray counts were converted into oxide weight percent-
ages by using the PAP correction program supplied by CAME-
CA. Quantitative chemical analysis was calculated on the
average of 10 single spots and atoms per formula unit on the
basis of 12 oxygen atoms.
Three porcine St Jude Medical Bioimplant xenografts im-
planted in human subjects as mitral valve substitutes and
explanted because of calcific structural valve deterioration
(time in place, 108 ± 25.63 months) were used as control
grafts and submitted to the same investigation protocol. This
model of porcine bioprostheses was selected because it was
the same as used in vitro and because there was no calcium
mitigation treatment.
Results
All in vitro tested bioprostheses appeared heavily cal-
cified at gross and x-ray examination (score, 4 each),
either on the cusp body or the commissures; two cases
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presented with eggshell cusp fragmentation (Table I
and Fig 2, A and B). At atomic absorption spectroscopy,
calcium content ranged from 111.11 to 259.66 mg/g
dry weight (mean, 205.285 ± 64.87 mg/g dry weight;
Table I). At histology, Von Kossa stain disclosed intrin-
sic calcification, both nodular and laminar, involving
either the fibrosa or the spongiosa (Fig 3, A and B); cal-
cification regularly involved the muscle shelf of the
right cusp. Films of calcific deposits on the cusp sur-
face were rare and negligible in amount. Calcium depo-
sitions were also visible in the aortic wall tunica media
on smooth muscle cells (Fig 3, C and D). At TEM, cal-
cification involved mostly microstructural components,
such as collagen fibrils and interfibrillar spaces, and,
more rarely, cells, including nuclei and cytoplasm
organelles and debris; plate-like calcific deposits were
also observed (Fig 4). XRPD technique disclosed the
presence of diffraction peaks, which are in keeping
with apatite Ca5(PO4)3(OH,Cl) (Fig 5, A). Because of
the large amount of organic tissue in the samples, the
background radiation was particularly high. EMPA
analysis detected calcium phosphate, with a Ca/P
atoms ratio of 4.5:3 (Table II, A and B), a value inter-
mediate between that of apatite (5:3) and octacalci-
Fig 1.  Pulsatile accelerated testing device. a, Mounted bioprosthetic on the cylinder; b, test chamber containing
the calcification fluid; c, housing; d, bypass; e, choke; f, rotating swash plate with adjustment of plate inclination;
α, angle of inclination.
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umphosphate (4:3), a metastable precursor of apatite,
with the formula Ca4H(PO4)3 2.5H2O and a similar
XRPD pattern. Scanning electron microscopy investi-
gation showed the presence of euhedral aggregates of
exhagonal tabular crystals up to about 8 µm in size,
showing well-developed basal pinacoids (Fig 5, B), a
clear-cut morphologic finding consistent with hexago-
nal habitus of apatite.
The 3 human explants failed because of incompetence
caused by calcific commissural tearing. At gross inspec-
tion and x-ray examination, massive calcification (score,
4 each) was detected. Histology disclosed intrinsic nodu-
lar calcific deposits, which, at TEM, resulted in involved
collagen fibers and, more rarely, cell debris (Figs 6 and
7). At atomic absorption spectroscopy, a mean mineral-
ization value of 106.03 ± 7.02 mg/g dry weight (ranging
from 101.07 to 168.94 mg/g) was found. The XRPD
showed sharp picks, which is in keeping with well-crys-
tallized apatite precipitates (Fig 8).
Discussion
Calcification of biologic tissues occurs in 2 different
phases, namely, nucleation and propagation.13 Nuclea-
tion is very critical because in biologic fluids calcium
and phosphate are insufficient to allow a spontaneous
precipitation of hydroxyapatite from their preliminary
compounds, namely, amorphous calcium phosphate and
octacalciumphosphate. At the site of calcification, a
localized microenvironment occurs in which concen-
trations of calcium and phosphate are elevated to the
point of apatite precipitation. During bone formation,
this process is mainly due to the action of energy-
requiring phosphatase concentrated in the matrix vesi-
cles. Instead, a non–energy-requiring Ca2+ trap has
been postulated to occur in cartilage ossification as a
result of phosphatidyl-serine and other phospholipids
through the formation of calcium-phospholipidic com-
plexes, which can also nucleate hydroxyapatite from
metastable calcium phosphate solution.14,15 It has been
postulated that octacalciumphosphate is a preliminary
compound of hydroxyapatite in cartilage mineraliza-
tion. This non–energy-requiring process is most proba-
bly responsible for bioprosthetic calcification, in which
cells are devitalized by glutaraldehyde treatment. In
fact, viable cells have an approximately 10,000-fold
gradient of calcium from outside to inside (10–3 vs 10–7
mol/L). Low intracellular calcium concentrations are
maintained by energy-dependent pumps at the cell
membranes. In cells rendered nonviable by glutaralde-
hyde fixation, calcium pumps are impaired, and calci-
um passively diffuses into the cytoplasm and reacts
with phospholipids of cell and organelle mem-
branes.5,16 Once nucleation has occurred, the concen-
tration of calcium and phosphate in metastable fluids is
sufficient for crystal propagation. Calcification of bio-
Fig 2.  Case 4. A, Gross view: diffuse calcium deposition with eggshell cusp fragmentation. B, X-ray view: mas-
sive mineralization (score 4).
Table I. X-ray scores and calcium contents
Sample No. X-ray Ca content (mg/g dry weight)*
1 4 111.11
2 4 223.16
3 4 259.66
4 4 227.21
*Mean: 205.285 ± 64.87 mg/g.
A B
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Fig 3. Case 4. A, Cuspal intrinsic calcium deposits at histologic examination. (Von Kossa stain; original magnifi-
cation, 12×.) B, Higher magnification of A. (Von Kossa stain; original magnification, 36×.) C, Calcium deposits in
the aortic wall tunica media. (Von Kossa stain; original magnification, 36×.) D, Higher magnification of C.
Calcification involves smooth muscle cells. (Von Kossa stain; original magnification, 240×.)
A B
C D
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prostheses implanted in vivo, which at first occurs on
cell membranes and then involves collagen fibers and
interfibrillar spaces,3,4 has been proven to consist of
hydroxyapatite.
Calcification has been reproduced in vitro. Bernacca
and colleagues,17 studying bovine pericardial valves by
means of an in vitro fatigue tester method with various
test media, including bovine plasma, found large calci-
um deposits at histologic examination. Nevertheless, it
was not clear whether this calcium deposition was a
generalized precipitation limited to the biomaterial sur-
faces (extrinsic calcification) or involved structural bio-
prosthetic components (intrinsic calcification).18 Dei-
wick,9 Glasmacher,10 and their colleagues developed a
protocol for accelerated in vitro valve calcification
and were able to reproduce massive calcification in
vitro. They demonstrated, by means of weekly x-ray
examination, that mineralization was initially mini-
mal and then increased in an exponential way. By
using holographic interferometry, they demonstrated
a strong correlation between holographic anomalies
and bioprosthetic calcification. This protocol was
applied also to the porcine bioprostheses herein inves-
tigated in vitro, with the purpose of verifying whether
calcification was structurally and biochemically simi-
lar to that occurring in bioprostheses implanted in
vivo. We found massive and extensive calcification
both at gross and x-ray examination. Histologic and
ultrastructural features were quite similar to those
observed in the same type of porcine bioprostheses
Table IIA. EMPA: Analysis in oxides, % (averaged on 10-spot analysis)
MgO Al2O3 P2O5 SO3 Cl* CaO Oxidestot
Mean ± SD 0.03 ± 0.03 0.02 ± 0.02 35.68 ± 4.11 0.05 ± 0.05 0.44 ± 0.38 41.14 ± 5.04 77.36 ± 8.58
*Cl is expressed as hypothetic Cl2O.
Table IIB. EMPA: Atoms per formula unit calculated on the basis of the 12 oxygen atoms (Ca5[PO4]3[OH])
Mg Al P S Cl Ca Total cations
Mean ± SD 0.004 ± 0.004 0.002 ± 0.003 3.020 ± 0.054 0.004 ± 0.004 0.056 ± 0.056 4.463 ± 0.138 7.489 ± 0.083
Fig 4. Case 3. TEM with calcification involving collagen fibers. Note the plate-like features. (Original magnifica-
tion, 24,000×.)
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explanted from patients. The prevalent involvement of
collagen matrix at TEM may be explained by the
advanced calcification. The XRPD technique dis-
closed the presence of the most intense diffraction
peaks in keeping with apatite. Quantitative EMPA
analysis of in vitro tested bioprostheses shows a Ca/P
ratio of 4.5:3, which is lower than that of pure apatite
(5:3) and higher than that of octacalciumphosphate
(4:3). The finding of a 4.5:3 Ca/P ratio in the in vitro
tested bioprostheses could be explained in terms of
rapid coprecipitation of 2 calcium phosphate com-
pounds: apatite and the metastable octacalciumphos-
phate.19 This hypothesis will require further investiga-
tion, but the presence of octacalciumphosphate agrees
with the de novo precipitation of hydroxyapatite and
with the mechanism of the non–energy-requiring Ca2+
A
B
Fig 5.  Case 1. A, XRPD (CuKα1,2) patterns of an in vitro tested sample in the 2θ range of 24˚ to 55˚. Step-by-step
data collection is shown, with a step width of 0.02˚ and a counting time of 2 seconds per step. The presence of the
peaks is consistent with apatite. B, At scanning electron microscopy, platelike aggregates up to 8 µm in size are
clearly visible. The aggregates reveal a tabular hexagonal shape consistent with crystals of apatite. (Original mag-
nification, 30,000×.)
The Journal of Thoracic and
Cardiovascular Surgery
Volume 121, Number 3
Pettenazzo et al 507
Fig 6. St Jude Medical Bioimplant xenograft in place in human mitral position for 84 months. A, Gross view of the
inflow surface with coarse calcification. B, Score 4 calcification at x-ray examination. C, Intrinsic calcification at
histology. (Von Kossa stain; original magnification, 12×.) D, Close up of C. (Von Kossa stain; original magnifica-
tion, 36×.)
A B
C D
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trap by phospholipids, as described in cartilage min-
eralization.14
In vivo test models (subdermal implantation in rats
and orthotopic implantation in juvenile sheep) are
extensively used, but they show remarkable variability
as a result of individual host factors, which render unre-
liable the results when evaluating anticalcification
strategies.20 All our explants from in vitro calcification
showed severe mineralization and calcium content at
atomic absorption spectroscopy of well over 100 mg/g
Fig 7. TEM of the same human porcine xenograft shown in Fig 6. Note calcification mostly involving collagen
fibers. (Original magnification, 24,000×.)
Fig 8. XRPD (CuKα1,2) patterns (2θ range, 24˚-55˚) of the same human porcine xenograft as shown in Fig 6. Step-
by-step data collection is shown, with a step width of 0.02˚ and a counting time of 2 seconds per step. The pres-
ence of the sharp peaks is consistent with massive well-crystallized apatite.
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dry weight each. These findings suggest less variability
of mineralization in the long term of in vitro testing than
that observed in in vivo test models.8,21 Thus, the in
vitro test model, which allows for calcification of tested
valves with identical well-controlled conditions and
with the opportunity to directly observe the ongoing cal-
cification process (x-ray) during the test period,22,23
seems to be superior to the in vivo models. The cost of
the test device is appealing, amounting to about $4000,
and the cost during testing is negligible because of the
relatively cheap chemical components of the solution
(barbital buffer, calcium, and phosphate). Overall, the
test compares favorably with rat subcutaneous implants.
In conclusion, bioprosthetic calcification obtained in
vitro is similar to that occurring in bioprostheses im-
planted in vivo. The model may be of value to acceler-
ate the screening of anticalcific agents and may reduce
the need for animal experiments. Studies comparing
different calcium mitigation treatments are in progress.
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